These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 2554504)

  • 21. [A new treatment of deep venous thrombosis: low molecular weight heparin fractions. Randomized study].
    Faivre R; Neuhart Y; Kieffer Y; Apfel F; Magnin D; Didier D; Toulemonde F; Bassand JP; Maurat JP
    Presse Med; 1988 Feb; 17(5):197-200. PubMed ID: 2965375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapeutic fibrinolysis].
    Straub PW
    Schweiz Med Wochenschr; 1973 May; 103(20):753-7. PubMed ID: 4702993
    [No Abstract]   [Full Text] [Related]  

  • 23. [Pulmonary embolism: what happens to the emboligenic focus?].
    Serradimigni A; Philip F; Elias A; Lecorff G
    Haemostasis; 1986; 16 Suppl 4():69-78. PubMed ID: 3770559
    [No Abstract]   [Full Text] [Related]  

  • 24. Pulmonary embolism.
    Schrijvers D; Van den Brande J; Vermorken JB
    N Engl J Med; 1998 Nov; 339(21):1555; author reply 1557. PubMed ID: 9841332
    [No Abstract]   [Full Text] [Related]  

  • 25. The treatment of deep vein thrombosis and pulmonary embolism.
    Turkstra F; Koopman MM; Büller HR
    Thromb Haemost; 1997 Jul; 78(1):489-96. PubMed ID: 9198202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-molecular-weight heparin for PE.
    Grimm KJ; French L
    J Fam Pract; 1997 Dec; 45(6):467-8. PubMed ID: 9420575
    [No Abstract]   [Full Text] [Related]  

  • 27. Follow-up sonographic examinations at 3 and 6 months for patients with a diagnosis of deep vein thrombosis.
    Yucel EK
    AJR Am J Roentgenol; 1996 Nov; 167(5):1339-40. PubMed ID: 8911211
    [No Abstract]   [Full Text] [Related]  

  • 28. Coagulation parameters and success of thrombolytic treatment in deep vein thrombosis.
    Duckert F; Benz A; Prisender S; da Silva A; Schmitt HE
    Vasa; 1974; 3(2):138-9. PubMed ID: 4831536
    [No Abstract]   [Full Text] [Related]  

  • 29. Laboratory control of heparin and heparin fragment treatment: an experimental study.
    Doutremepuich C; Lalanne MC; Guyot M; Doutremepuich F; De Sèze O; Toulemonde F
    Semin Thromb Hemost; 1989 Oct; 15(4):373-7. PubMed ID: 2554497
    [No Abstract]   [Full Text] [Related]  

  • 30. Diagnostic and therapeutic management of patients with deep-vein thrombosis: coming to maturity?
    Büller HR; Koopman MM
    Neth J Med; 1996 Mar; 48(3):81-4. PubMed ID: 8935746
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of LMWH (tinzaparin) on coagulation and fibrinolytic activation in pregnant women at risk of thrombosis.
    Yoneda M; Brosnan JF; Norris LA; Bonnar J
    Thromb Res; 2006; 117(3):283-90. PubMed ID: 15869785
    [No Abstract]   [Full Text] [Related]  

  • 32. On thrombosis, thrombolysis and fibrinolysis. I. Thrombolytic therapy of deep venous thrombosis. II. Assay of individual fibrinolytic response.
    Robertson BR
    Acta Chir Scand Suppl; 1971; 421():1-51. PubMed ID: 5292287
    [No Abstract]   [Full Text] [Related]  

  • 33. Prevention of deep-vein thrombosis and pulmonary embolism after total hip replacement. Comparison of low-molecular-weight heparin and unfractionated heparin.
    Eriksson BI; Kälebo P; Anthymyr BA; Wadenvik H; Tengborn L; Risberg B
    J Bone Joint Surg Am; 1991 Apr; 73(4):484-93. PubMed ID: 2013587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis and treatment of venous thromboembolism in children and adolescents. On behalf of the Subcommittee on Perinatal Haemostasis of the Scientific and Standardization Committee of the ISTH.
    David M; Manco-Johnson M; Andrew M
    Thromb Haemost; 1995 Aug; 74(2):791-2. PubMed ID: 8585023
    [No Abstract]   [Full Text] [Related]  

  • 35. Initial treatment of venous thromboembolism.
    Kearon C
    Thromb Haemost; 1999 Aug; 82(2):887-91. PubMed ID: 10605798
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of pulmonary embolism and deep vein thrombosis with thrombolytic therapy.
    Volgesang GB; Bell WR
    Clin Chest Med; 1984 Sep; 5(3):487-94. PubMed ID: 6386293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pulmonary thromboembolism].
    Baloira Villar A; Ruiz Iturriaga LA
    Arch Bronconeumol; 2010 Oct; 46 Suppl 7():31-7. PubMed ID: 21316548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathophysiology and treatment of deep-vein thrombosis and pulmonary embolism.
    Carter BL; Jones ME; Waickman LA
    Clin Pharm; 1985; 4(3):279-96. PubMed ID: 3891200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitation of venous clot lysis with the D-dimer immunoassay during fibrinolytic therapy requires correction for soluble fibrin degradation.
    Brenner B; Francis CW; Totterman S; Kessler CM; Rao AK; Rubin R; Kwaan HC; Gabriel KR; Marder VJ
    Circulation; 1990 Jun; 81(6):1818-25. PubMed ID: 2111742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acyl-enzymes as thrombolytic agents in dog models of venous thrombosis and pulmonary embolism.
    Dupe RJ; English PD; Smith RA; Green J
    Thromb Haemost; 1984 Apr; 51(2):248-53. PubMed ID: 6234676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.